OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 30 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $124.200 million which missed the analyst consensus estimate of $130.514 million by 4.84 percent. This is a 17.14 percent decrease over sales of $149.900 million the same period last year.